Drotrecogin alfa (activated) treatment in severe sepsis: A "journal club" review of the global ENHANCE trial

J. Christopher Farmer

Research output: Contribution to journalEditorial

7 Scopus citations
Original languageEnglish (US)
Pages (from-to)2428-2431
Number of pages4
JournalCritical care medicine
Volume33
Issue number10
DOIs
StatePublished - Oct 2005

Keywords

  • Bleeding
  • Drotrecogin alfa (activated)
  • ENHANCE TRIAL

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this